Predisposing Factors to Abnormal First Trimester Placentation and the Impact on Fetal Outcomes

Seminars in Reproductive Medicine

Volumn 34, Issue 1, 2015, Pages 27-35

  Kroener, Lindsay ^a,b   Wang, Erica T ^a,b   Pisarska, Margareta D ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

abnormal placentation; assisted reproductive technology; first trimester placentation; IVF; NIFT; sex differences; trophoblast

Indexed keywords

ARTICLE; CELL INVASION; DISEASE PREDISPOSITION; EPIGENETICS; FEMALE; FETUS; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GENETICS; HUMAN; INFERTILITY THERAPY; INTRAUTERINE GROWTH RETARDATION; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY OUTCOME; SEX DIFFERENCE; SOLUTIO PLACENTAE; TROPHOBLAST; CAUSALITY; FERTILIZATION; FETUS DEVELOPMENT; GENE EXPRESSION; GENETIC EPIGENESIS; IN VITRO FERTILIZATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; REPRODUCTION; SEXUAL DEVELOPMENT; VASCULARIZATION;

CAUSALITY; EPIGENESIS, GENETIC; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; FETUS; GENE EXPRESSION; HUMANS; PLACENTA; PLACENTA DISEASES; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; REPRODUCTIVE TECHNIQUES, ASSISTED; SEX CHARACTERISTICS;

EID: 84951809852     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0035-1570029     Document Type: Article

References (120)

1. Roberts C. T. IFPA Award in Placentology Lecture: complicated interactions between genes and the environment in placentation, pregnancy outcome and long term health. Placenta: 2010; 31 (Suppl): S47 S53
2. O'Tierney-Ginn P. F., Lash G. E. Beyond pregnancy: modulation of trophoblast invasion and its consequences for fetal growth and long-term children's health. J Reprod Immunol: 2014; 104-105 37 42
3. Redman C. W., Sargent I. L. Latest advances in understanding preeclampsia. Science: 2005; 308 5728 1592 1594
4. Pijnenborg R., Vercruysse L., Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta: 2006; 27 9-10 939 958
5. Khong T. Y., De Wolf F., Robertson W. B., Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol: 1986; 93 10 1049 1059
6. Kim Y. M., Bujold E., Chaiworapongsa T., et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol: 2003; 189 4 1063 1069
7. La Sala G. B., Ardizzoni A., Capodanno F., et al. Protein microarrays on midtrimester amniotic fluids: a novel approach for the diagnosis of early intrauterine inflammation related to preterm delivery. Int J Immunopathol Pharmacol: 2012; 25 4 1029 1040
8. Shimonovitz S., Hurwitz A., Dushnik M., Anteby E., Geva-Eldar T., Yagel S. Developmental regulation of the expression of 72 and 92 kd type IV collagenases in human trophoblasts: a possible mechanism for control of trophoblast invasion. Am J Obstet Gynecol: 1994; 171 3 832 838
9. Chakraborty C., Gleeson L. M., McKinnon T., Lala P. K. Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol: 2002; 80 2 116 124
10. Lash G. E., Otun H. A., Innes B. A., Bulmer J. N., Searle R. F., Robson S. C. Low oxygen concentrations inhibit trophoblast cell invasion from early gestation placental explants via alterations in levels of the urokinase plasminogen activator system. Biol Reprod: 2006; 74 2 403 409
11. Genbacev O., Joslin R., Damsky C. H., Polliotti B. M., Fisher S. J. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest: 1996; 97 2 540 550
12. Burton G. J., Woods A. W., Jauniaux E., Kingdom J. C. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta: 2009; 30 6 473 482
13. Andraweera P. H., Dekker G. A., Roberts C. T. The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update: 2012; 18 4 436 457
14. Helske S., Vuorela P., Carpén O., Hornig C., Weich H., Halmesmäki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod: 2001; 7 2 205 210
15. Nevo O., Lee D. K., Caniggia I. Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta. PLoS ONE: 2013; 8 11 e81176
16. Orendi K., Kivity V., Sammar M., et al. Placental and trophoblastic in vitro models to study preventive and therapeutic agents for preeclampsia. Placenta: 2011; 32 (Suppl): S49 S54
17. Graham C. H., Hawley T. S., Hawley R. G., et al. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res: 1993; 206 2 204 211
18. Straszewski-Chavez S. L., Abrahams V. M., Alvero A. B., et al. The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71. Placenta: 2009; 30 11 939 948
19. Barker D. J., Eriksson J. G., Forsén T., Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol: 2002; 31 6 1235 1239
20. Barker D. J. Adult consequences of fetal growth restriction. Clin Obstet Gynecol: 2006; 49 2 270 283
21. Barker D. J., Lampl M., Roseboom T., Winder N. Resource allocation in utero and health in later life. Placenta: 2012; 33 02 e30 e34
22. Rinaudo P., Wang E. Fetal programming and metabolic syndrome. Annu Rev Physiol: 2012; 74 107 130
23. Calkins K., Devaskar S. U. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care: 2011; 41 6 158 176
24. Kajantie E., Eriksson J. G., Osmond C., Thornburg K., Barker D. J. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke: 2009; 40 4 1176 1180
25. Kajantie E., Osmond C., Barker D. J., Forsén T., Phillips D. I., Eriksson J. G. Size at birth as a predictor of mortality in adulthood: a follow-up of 350 000 person-years. Int J Epidemiol: 2005; 34 3 655 663
26. Fowden A. L., Coan P. M., Angiolini E., Burton G. J., Constancia M. Imprinted genes and the epigenetic regulation of placental phenotype. Prog Biophys Mol Biol: 2011; 106 1 281 288
27. Haig D. Altercation of generations: genetic conflicts of pregnancy. Am J Reprod Immunol: 1996; 35 3 226 232
28. Petry C. J., Ong K. K., Dunger D. B. Does the fetal genotype affect maternal physiology during pregnancy? Trends Mol Med: 2007; 13 10 414 421
29. Reik W., Constância M., Fowden A., et al. Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J Physiol: 2003; 547 (Pt 1): 35 44
30. Bressan F. F., De Bem T. H., Perecin F., et al. Unearthing the roles of imprinted genes in the placenta. Placenta: 2009; 30 10 823 834
31. Jaquet D., Swaminathan S., Alexander G. R., et al. Significant paternal contribution to the risk of small for gestational age. BJOG: 2005; 112 2 153 159
32. Zetterström K., Lindeberg S., Haglund B., Magnuson A., Hanson U. Being born small for gestational age increases the risk of severe pre-eclampsia. BJOG: 2007; 114 3 319 324
33. Duckitt K., Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ: 2005; 330 7491 565
34. Lie R. T., Rasmussen S., Brunborg H., Gjessing H. K., Lie-Nielsen E., Irgens L. M. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ: 1998; 316 7141 1343 1347
35. Nelissen E. C., van Montfoort A. P., Dumoulin J. C., Evers J. L. Epigenetics and the placenta. Hum Reprod Update: 2011; 17 3 397 417
36. Feinberg A. P. Epigenetics at the epicenter of modern medicine. JAMA: 2008; 299 11 1345 1350
37. Feinberg A. P. Genome-scale approaches to the epigenetics of common human disease. Virchows Arch: 2010; 456 1 13 21
38. Lister R., Pelizzola M., Dowen R. H., et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature: 2009; 462 7271 315 322
39. Ferretti C., Bruni L., Dangles-Marie V., Pecking A. P., Bellet D. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update: 2007; 13 2 121 141
40. Koslowski M., Sahin U., Mitnacht-Kraus R., Seitz G., Huber C., Türeci O. A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes. Cancer Res: 2007; 67 19 9528 9534
41. Dokras A., Coffin J., Field L., et al. Epigenetic regulation of maspin expression in the human placenta. Mol Hum Reprod: 2006; 12 10 611 617
42. Wong N. C., Novakovic B., Weinrich B., et al. Methylation of the adenomatous polyposis coli (APC) gene in human placenta and hypermethylation in choriocarcinoma cells. Cancer Lett: 2008; 268 1 56 62
43. Novakovic B., Rakyan V., Ng H. K., et al. Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts. Mol Hum Reprod: 2008; 14 9 547 554
44. Mayer W., Niveleau A., Walter J., Fundele R., Haaf T. Demethylation of the zygotic paternal genome. Nature: 2000; 403 6769 501 502
45. Santos F., Hendrich B., Reik W., Dean W. Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev Biol: 2002; 241 1 172 182
46. Serman L., Vlahović M., Sijan M., et al. The impact of 5-azacytidine on placental weight, glycoprotein pattern and proliferating cell nuclear antigen expression in rat placenta. Placenta: 2007; 28 8-9 803 811
47. Rahnama F., Shafiei F., Gluckman P. D., Mitchell M. D., Lobie P. E. Epigenetic regulation of human trophoblastic cell migration and invasion. Endocrinology: 2006; 147 11 5275 5283
48. Xu N., Chua A. K., Jiang H., Liu N. A., Goodarzi M. O. Early embryonic androgen exposure induces transgenerational epigenetic and metabolic changes. Mol Endocrinol: 2014; 28 8 1329 1336
49. Doherty A. S., Mann M. R., Tremblay K. D., Bartolomei M. S., Schultz R. M. Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol Reprod: 2000; 62 6 1526 1535
50. Song S., Ghosh J., Mainigi M., et al. DNA methylation differences between in vitro- and in vivo-conceived children are associated with ART procedures rather than infertility. Clin Epigenetics: 2015; 7 1 41
51. Katari S., Turan N., Bibikova M., et al. DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum Mol Genet: 2009; 18 20 3769 3778
52. Moore G. E., Ishida M., Demetriou C., et al. The role and interaction of imprinted genes in human fetal growth. Philos Trans R Soc Lond B Biol Sci: 2015; 370 1663 20140074
53. Frost J. M., Moore G. E. The importance of imprinting in the human placenta. PLoS Genet: 2010; 6 7 e1001015
54. Reik W., Dean W., Walter J. Epigenetic reprogramming in mammalian development. Science: 2001; 293 5532 1089 1093
55. Hemberger M. Epigenetic landscape required for placental development. Cell Mol Life Sci: 2007; 64 18 2422 2436
56. Apostolidou S., Abu-Amero S., O'Donoghue K., et al. Elevated placental expression of the imprinted PHLDA2 gene is associated with low birth weight. J Mol Med (Berl): 2007; 85 4 379 387
57. Pozharny Y., Lambertini L., Ma Y., et al. Genomic loss of imprinting in first-trimester human placenta. Am J Obstet Gynecol: 2010; 202 4 391.e1 391.e8
58. Constância M., Hemberger M., Hughes J., et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature: 2002; 417 6892 945 948
59. Parker S. E., Werler M. M. Epidemiology of ischemic placental disease: a focus on preterm gestations. Semin Perinatol: 2014; 38 3 133 138
60. Brosens I., Pijnenborg R., Vercruysse L., Romero R. The Great Obstetrical Syndromes are associated with disorders of deep placentation. Am J Obstet Gynecol: 2011; 204 3 193 201
61. Ananth C. V., Vintzileos A. M. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol: 2006; 195 6 1557 1563
62. Blencowe H., Cousens S., Oestergaard M. Z., et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet: 2012; 379 9832 2162 2172
63. Saigal S., Doyle L. W. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet: 2008; 371 9608 261 269
64. Lykke J. A., Langhoff-Roos J., Sibai B. M., Funai E. F., Triche E. W., Paidas M. J. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension: 2009; 53 6 944 951
65. Lisonkova S., Joseph K. S. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol: 2013; 209 6 544.e1 544.e12
66. Ness R. B., Sibai B. M. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol: 2006; 195 1 40 49
67. Roberts J. M., Taylor R. N., Musci T. J., Rodgers G. M., Hubel C. A., McLaughlin M. K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol: 1989; 161 5 1200 1204
68. Dildy G. A. III, Belfort M. A., Smulian J. C. Preeclampsia recurrence and prevention. Semin Perinatol: 2007; 31 3 135 141
69. Kajantie E., Thornburg K. L., Eriksson J. G., Osmond C., Barker D. J. In preeclampsia, the placenta grows slowly along its minor axis. Int J Dev Biol: 2010; 54 2-3 469 473
70. Kovo M., Schreiber L., Ben-Haroush A., Wand S., Golan A., Bar J. Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction. Am J Obstet Gynecol: 2010; 202 6 561.e1 561.e5
71. Levine R. J., Maynard S. E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med: 2004; 350 7 672 683
72. Lash G. E., Taylor C. M., Trew A. J., et al. Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions. Growth Factors: 2002; 20 4 189 196
73. Yong H. E., Melton P. E., Johnson M. P., et al. Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes. PLoS ONE: 2015; 10 5 e0128230
74. Copel J. A., Bahtiyar M. O. A practical approach to fetal growth restriction. Obstet Gynecol: 2014; 123 5 1057 1069
75. Mayhew T. M., Charnock-Jones D. S., Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta: 2004; 25 2-3 127 139
76. Taylor R. N., Grimwood J., Taylor R. S., McMaster M. T., Fisher S. J., North R. A. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol: 2003; 188 1 177 182
77. Villar J., Carroli G., Wojdyla D., et al. World Health Organization Antenatal Care Trial Research Group. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol: 2006; 194 4 921 931
78. Ananth C. V., Peltier M. R., Chavez M. R., Kirby R. S., Getahun D., Vintzileos A. M. Recurrence of ischemic placental disease. Obstet Gynecol: 2007; 110 1 128 133
79. Ananth C. V. Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption. Semin Perinatol: 2014; 38 3 131 132
80. Ananth C. V., Williams M. A. Placental abruption and placental weight - implications for fetal growth. Acta Obstet Gynecol Scand: 2013; 92 10 1143 1150
81. Klemetti R., Gissler M., Sevón T., Koivurova S., Ritvanen A., Hemminki E. Children born after assisted fertilization have an increased rate of major congenital anomalies. Fertil Steril: 2005; 84 5 1300 1307
82. Jackson R. A., Gibson K. A., Wu Y. W., Croughan M. S. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol: 2004; 103 3 551 563
83. Hansen M., Kurinczuk J. J., Bower C., Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med: 2002; 346 10 725 730
84. Strömberg B., Dahlquist G., Ericson A., Finnström O., Köster M., Stjernqvist K. Neurological sequelae in children born after in-vitro fertilisation: a population-based study. Lancet: 2002; 359 9305 461 465
85. Schieve L. A., Meikle S. F., Ferre C., Peterson H. B., Jeng G., Wilcox L. S. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med: 2002; 346 10 731 737
86. Verlaenen H., Cammu H., Derde M. P., Amy J. J. Singleton pregnancy after in vitro fertilization: expectations and outcome. Obstet Gynecol: 1995; 86 6 906 910
87. Hiura H., Okae H., Chiba H., et al. Imprinting methylation errors in ART. Reprod Med Biol: 2014; 13 4 193 202
88. Lazaraviciute G., Kauser M., Bhattacharya S., Haggarty P., Bhattacharya S. A systematic review and meta-analysis of DNA methylation levels and imprinting disorders in children conceived by IVF/ICSI compared with children conceived spontaneously. Hum Reprod Update: 2014; 20 6 840 852
89. Sunderam S., Kissin D. M., Crawford S. B., Folger S. G., Jamieson D. J., Barfield W. D.; Centers for Disease Control and Prevention (CDC). Assisted reproductive technology surveillance-United States, 2011. MMWR Surveill Summ: 2014; 63 10 1 28
90. Romundstad L. B., Romundstad P. R., Sunde A., et al. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet: 2008; 372 9640 737 743
91. Delle Piane L., Lin W., Liu X., et al. Effect of the method of conception and embryo transfer procedure on mid-gestation placenta and fetal development in an IVF mouse model. Hum Reprod: 2010; 25 8 2039 2046
92. Bloise E., Lin W., Liu X., et al. Impaired placental nutrient transport in mice generated by in vitro fertilization. Endocrinology: 2012; 153 7 3457 3467
93. Feuer S. K., Liu X., Donjacour A., et al. Use of a mouse in vitro fertilization model to understand the developmental origins of health and disease hypothesis. Endocrinology: 2014; 155 5 1956 1969
94. Collier A. C., Miyagi S. J., Yamauchi Y., Ward M. A. Assisted reproduction technologies impair placental steroid metabolism. J Steroid Biochem Mol Biol: 2009; 116 1-2 21 28
95. Paulson R. J., Boostanfar R., Saadat P., et al. Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age. JAMA: 2002; 288 18 2320 2323
96. Sauer M. V., Paulson R. J., Lobo R. A. Oocyte donation to women of advanced reproductive age: pregnancy results and obstetrical outcomes in patients 45 years and older. Hum Reprod: 1996; 11 11 2540 2543
97. Wiggins D. A., Main E. Outcomes of pregnancies achieved by donor egg in vitro fertilization-a comparison with standard in vitro fertilization pregnancies. Am J Obstet Gynecol: 2005; 192 6 2002 2006, discussion 2006-2008
98. Kaser D. J., Melamed A., Bormann C. L., et al. Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertil Steril: 2015; 103 5 1176 84.e2
99. Jackson S., Hong C., Wang E. T., Alexander C., Gregory K. D., Pisarska M. D. Pregnancy outcomes in very advanced maternal age pregnancies: the impact of assisted reproductive technology. Fertil Steril: 2015; 103 1 76 80
100. Conway D. A., Liem J., Patel S., Fan K. J., Williams J. III, Pisarska M. D. The effect of infertility and assisted reproduction on first-trimester placental and fetal development. Fertil Steril: 2011; 95 5 1801 1804
101. Conway D. A., Patel S. S., Liem J., et al. The risk of cytogenetic abnormalities in the late first trimester of pregnancies conceived through assisted reproduction. Fertil Steril: 2011; 95 2 503 506
102. Huang A., Adusumalli J., Patel S., Liem J., Williams J. III, Pisarska M. D. Prevalence of chromosomal mosaicism in pregnancies from couples with infertility. Fertil Steril: 2009; 91 6 2355 2360
103. Basso O., Baird D. D. Infertility and preterm delivery, birthweight, and Caesarean section: a study within the Danish National Birth Cohort. Hum Reprod: 2003; 18 11 2478 2484
104. Giritharan G., Talbi S., Donjacour A., Di Sebastiano F., Dobson A. T., Rinaudo P. F. Effect of in vitro fertilization on gene expression and development of mouse preimplantation embryos. Reproduction: 2007; 134 1 63 72
105. Farhi J., Ben-Haroush A., Andrawus N., et al. High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation. Reprod Biomed Online: 2010; 21 3 331 337
106. Kalra S. K., Ratcliffe S. J., Coutifaris C., Molinaro T., Barnhart K. T. Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization. Obstet Gynecol: 2011; 118 4 863 871
107. Kent A. L., Wright I. M., Abdel-Latif M. E.; New South Wales and Australian Capital Territory Neonatal Intensive Care Units Audit Group. Mortality and adverse neurologic outcomes are greater in preterm male infants. Pediatrics: 2012; 129 1 124 131
108. Ingemarsson I. Gender aspects of preterm birth. BJOG: 2003; 110 20 34 38
109. Bacak S. J., Baptiste-Roberts K., Amon E., Ireland B., Leet T. Risk factors for neonatal mortality among extremely-low-birth-weight infants. Am J Obstet Gynecol: 2005; 192 3 862 867
110. Rankin J., Pearce M. S., Bell R., Glinianaia S. V., Parker L. Perinatal mortality rates: adjusting for risk factor profile is essential. Paediatr Perinat Epidemiol: 2005; 19 1 56 58
111. Lauterbach M. D., Raz S., Sander C. J. Neonatal hypoxic risk in preterm birth infants: the influence of sex and severity of respiratory distress on cognitive recovery. Neuropsychology: 2001; 15 3 411 420
112. Stevenson D. K., Verter J., Fanaroff A. A., et al. Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch Dis Child Fetal Neonatal Ed: 2000; 83 3 F182 F185
113. Clifton V. L. Review: Sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta: 2010; 31 (Suppl): S33 S39
114. Murji A., Proctor L. K., Paterson A. D., Chitayat D., Weksberg R., Kingdom J. Male sex bias in placental dysfunction. Am J Med Genet A: 2012; 158A 4 779 783
115. Sood R., Zehnder J. L., Druzin M. L., Brown P. O. Gene expression patterns in human placenta. Proc Natl Acad Sci U S A: 2006; 103 14 5478 5483
116. Gabory A., Roseboom T. J., Moore T., Moore L. G., Junien C. Placental contribution to the origins of sexual dimorphism in health and diseases: sex chromosomes and epigenetics. Biol Sex Differ: 2013; 4 1 5
117. Mittwoch U. Blastocysts prepare for the race to be male. Hum Reprod: 1993; 8 10 1550 1555
118. Cuffe J. S., Walton S. L., Singh R. R., et al. Mid- to late term hypoxia in the mouse alters placental morphology, glucocorticoid regulatory pathways and nutrient transporters in a sex-specific manner. J Physiol: 2014; 592 (Pt 14): 3127 3141
119. Horie K., Takakura K., Fujiwara H., Suginami H., Liao S., Mori T. Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression. Hum Reprod: 1992; 7 2 184 190
120. Ghidini A., Salafia C. M. Gender differences of placental dysfunction in severe prematurity. BJOG: 2005; 112 2 140 144